PHG

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

Wall Street analysts forecast PHG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHG is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Koninklijke Philips NV revenue for the last quarter amounts to 5.03B USD, increased 4.56 % YoY.

Koninklijke Philips NV. EPS for the last quarter amounts to 0.22 USD, increased 4.76 % YoY.

Koninklijke Philips NV (PHG) has 67823 emplpoyees as of January 10 2026.

Today PHG has the market capitalization of 28.13B USD.